Sorafenib a tyrosine kinase inhibitor is used to treat which of the following?: (A) Myeloproliferative disorder, (B) Follicular lymphoma, (C) Medullary carcinoma thyroid, (D) Hepatocellular carcinoma
Answer is D. Sorafenib is used to treat hepatoma which are not resectable as a palliative measure. Ref: arrisons Principles of Internal Medicine, 18th Edition, Page 783.